Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 21, 2022 09:00 ET | Source: 22nd Century Group, Inc

22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules

BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural biotechnology company dedicated to improving human health with reduced nicotine...
June 16, 2022 08:30 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO

CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century GroupIntegration of GVB Biopharma Proceeding at a Rapid Pace BUFFALO, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group,...
May 27, 2022 09:25 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings

BUFFALO, N.Y., May 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine...
May 23, 2022 09:25 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business

Highly Regarded for His Extensive Sales and Marketing Experience in the Tobacco Industry Expands and Further Strengthens the Company’s Team of Tobacco Industry Experts BUFFALO, N.Y., May 23, 2022 ...
May 18, 2022 16:30 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform

Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMOConsistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for...
May 13, 2022 09:16 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company

Provides Transformational Platform to Rapidly Grow Hemp/Cannabis FranchiseTransaction Immediately Accretive and Will Double Company’s Total RevenueAdds Significant Commercial Scale to Existing...
May 05, 2022 06:00 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022

Launched VLN® Pilot Program in Chicago with Circle K as First Retail Trade PartnerBegan VLN® Shipments to South Korea for First International LaunchFDA’s Proposed Menthol Ban Could Leave VLN® Menthol...
April 28, 2022 09:30 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders

BUFFALO, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
April 27, 2022 09:25 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference

BUFFALO, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
April 14, 2022 08:00 ET | Source: 22nd Century Group, Inc

22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022

BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...